secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001437749-22-010347
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics raises $3.55M in private placement at $1.00/share with insider participation
--------------------------------------------------------------------------------

- Sold 3,550,000 shares of common stock at $1.00 per share for gross proceeds of $3,550,000.
- Insider investors include CEO/CFO David Jorden ($10,532), director Scott Pittman ($100,000), COO Peter Clausen ($25,000), and principal holder Charles Sheedy ($804,868).
- Proceeds to be used for working capital; post-offering shares outstanding increase to 40,674,205.
- Shares issued under Section 4(a)(2) and Rule 506 in unregistered transaction; company not current in SEC reports.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922010347/0001437749-22-010347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922010347/aurx20220427_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-010347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer